Nominated by President Trump to lead the FDA as commissioner, Scott Gottlieb, 44, formerly practiced as a physician, is a clinical assistant professor of medicine at New York University, a resident fellow at the American Enterprise Institute, and the former deputy commissioner of FDA under the George W. Bush administration. While critics complain that Gottlieb has numerous industry conflicts of interest, supporters expect he will advocate for faster approvals and more liberal drug marketing guidelines. The Senate Committee on Health, Education, Labor and Pensions conducted a confirmation hearing April 5.
[/membership][membership level=”0,4″][The content continues for paid members only.]
Login or Subscribe [/membership][membership level=”1,5,6,7,8,9,10,11,12″][membership]
